MarketBeat
08 Aug 2026, 05:04 UTC · 4h ago
Doximity Q1 Earnings Call Highlights
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
MarketBeat
08 Aug 2026, 05:04 UTC · 4h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
5 claims · each scored for market impact
Doximity raised its full-year revenue outlook to $671 million - $681 million, following a first-quarter beat on both revenue and adjusted EBITDA. — Guidance raises and earnings beats are primary catalysts for immediate positive stock price movement.
+0.60The company's AI Scribe usage grew 10-fold in July YoY, and the 'Doximity Ask' model recorded the lowest error rate (4.8%) among U.S. models in the NOHARM study. — Strong adoption and third-party validation of AI safety provide a competitive moat and long-term growth narrative in a high-risk clinical setting.
+0.50Doximity launched 'AI Search,' which is accessing new pharmaceutical budgets and generating over 10 times more revenue per query than the cost to run it. — New product monetization with high margins indicates a scalable revenue stream beyond existing subscriptions.
+0.40Continue reading
6 related stories
Top 3 movers · tap to explore
Doximity has signed 165 health-system AI clients, including prestigious institutions like Northwestern and Penn Medicine. — Enterprise adoption by top-tier hospitals validates the product-market fit and creates high switching costs.
+0.30Fiscal second-quarter revenue growth is forecast at only 1% (midpoint), reflecting a difficult year-over-year comparison. — A significant deceleration in quarterly growth rates can lead to short-term investor caution despite the annual outlook raise.
-0.20Which stocks this story touches
The company beat revenue and EBITDA guidance, raised its full-year outlook, and reported strong AI tool adoption and safety ratings.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
MarketBeat
2h ago
